Keywords: Australia, R&D tax credits, Medicines Australia

Australia’s pharma industry welcomes R&D tax credit, saying it will deliver real benefit to economy

Article | 18 June 2010

The introduction of a new 40% R&D tax credit will help keep Australia at the forefront of medical research, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in